Smart planning can reduce scours risk and help maintain antimicrobial effectiveness. Dr. Brett Terhaar, has practical tips ...

PRINCETON, N.J.--(BUSINESS WIRE)--ArrePath, an anti-infective drug discovery company addressing the global health challenge of drug resistant infections, announced today that it has raised $20 million ...

This Collection invites perspectives on the historical, socio-cultural and bio-medical facets of anti-infectives, including failure and success stories of anti-infective drugs, a discourse of ...

Recce Pharmaceuticals’ synthetic gel successfully treated a range of skin infections in a phase 2 trial, leading the Australian biotech to point to the anti-infective's potential to counter ...

Orthogon Therapeutics, a privately held research and development (R&D) company, uses principles of biophysics and structure-based drug design to develop anti-infective small molecules that selectively ...

MORRISTOWN, N.J.--(BUSINESS WIRE)--Melinta Therapeutics (Melinta) and Hikma Pharmaceuticals PLC (Hikma) today announced they have entered into an exclusive licensing agreement for Vabomere ® ...

Recce Pharmaceuticals has secured an Australian patent for its innovative anti-infective drugs, R327 and R529, ensuring its intellectual property protection in all major pharmaceutical markets until ...

Mumbai: Gujarat Themis Biosyn is making a decisive global push, betting on a high-value pharmaceutical portfolio to scale beyond its traditional base. The company has signed an agreement to acquire ...

CNW/ - Stoked Bio Inc., a Canadian biotechnology company focused on the development of novel anti-infectives and cancer ...

SYDNEY, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing a new class of synthetic anti-infectives, today announced the Australian Patent Office ...

Aicuris Anti-infective Cures AG has announced its intention to focus on the development and commercialization of anti-infectives for immunocompromised individuals, and will discontinue research ...

Tackling repeat surgeries: Optiscan’s imaging tech lets surgeons confirm tumour removal margins in real time, reducing the need for follow-up cancer surgeries. Boosting wound recovery: Aroa, PolyNovo, ...